摘要 |
A TGFP-CAP peptide is provided to show excellent anti-angiogenetic activity and whitening effect by blocking melanogenesis effectively, and exhibit excellent stability and skin permeability, thereby being applicable to medicines or cosmetics. A TGFP-CAP peptide comprises an amino acid sequence derived from TGF-beta1(transforming growth factor-beta1) and a cell adhesion amino acid sequence and is represented by a formula(1) of Ile-Trp-Ser-Leu-Asp-Thr-Gln-Tyr-cell adhesion amino acid sequence, wherein the amino acid sequence derived from TGF-beta1 consists of an amino acid sequence described as SEQ ID : NO. 1 and the cell adhesion amino acid sequence is RGD(Arg-Gly-Asp), RGDS(Arg-Gly-Asp-Ser), RGDC(Arg-Gly-Asp-Cys), RGDV(Arg-Gly-Asp-Val), RGES(Arg-Gly-Glu-Ser), RGDSPASSKP(Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro), GRGDS(Gly-Arg-Gly-Asp-Ser), GRADSP(Gly-Arg-Ala-Asp-Ser-Pro), KGDS(Lys-Gly-Asp-Ser), GRGDSP(Gly-Arg-Gly-Asp-Ser-Pro), GRGDTP(Gly-Arg-Gly-Asp-Thr-Pro), GRGES(Gly-Arg-Gly-Glu-Ser), GRGDSPC(Gly-Arg-Gly-Asp-Ser-Pro-Cys), GRGESP(Gly-Arg-Gly-Glu-Ser-Pro), SDGR(Ser-Asp-Gly-Arg), YRGDS(Tyr-Arg-Gly-Asp-Ser), GQQHHLGGAKQAGDV (Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val), GPR(Gly-Pro-Arg), GHK(Gly-His-Lys), YIGSR(Tyr-Ile-Gly-Ser-Arg), PDSGR(Pro-Asp-Ser-Gly-Arg), CDPGYIGSR(Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg), LCFR(Leu-Cys-Phe-Arg), EIL(Glu-Ile-Leu), EILDV(Glu-Ile-Leu-Asp-Val), EILDVPST(Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr), EILEVPST(Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr), LDV(Leu-Asp-Val) or LDVPS(Leu-Asp-Val-Pro-Ser). An anti-angiogenetic composition or a skin whitening composition comprises the peptide as an effective ingredient. |
申请人 |
CAREGEN CO., LTD. |
发明人 |
CHUNG, YONG JI;KIM, YOUNG DEUG;KIM, EUN MI;CHOI, JUN YOUNG;SEO, DONG SIK;KIM, JIN SEUK;SONG, SANG SU;CHO, KYOUNG MI |